Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing.

AGORANOV

Worldwide Innovation Challenge

European Commission

CARB-X

EASME - EU Executive Agency for SMEs

Seventure Partners

Khosla Ventures

Bpifrance

Sanofi Ventures

Eligo Bioscience

Exciting times at Eligo! Following our Series B announcement, we're gearing up to take the first-ever topical CRISPR therapy to the clinic. 
If you're eager to have a meaningful impact on the lives of millions of patients, we would love to hear from you. 
We are indeed on the lookout for passionate and driven individuals to join our Development, Finance, Synthetic Biology & Bioinformatics teams.

https://eligo.bio/careers/

🎉 News alert: We are thrilled to announce that we have just closed a $30 million financing round led by Sanofi Ventures, with the participation of Bpifrance (Innobio2), and our existing investors Khosla Ventures and Seventure Partners.

 🧬 This funding will enable us to advance and test in the clinic our CRISPR-based medicine for the 90M+ patients suffering from moderate-to-severe acne vulgaris. It will also help us to further develop our proprietary platform to address other immuno-inflammatory diseases, cancers, and infectious diseases.

 🚀 This is a defining moment for Eligo as this funding places us in a strong position to make a significant leap in treating diseases by editing the genetic makeup of the human microbiome.

#CRISPR #SyntheticBiology #GeneEditing #Microbiome #Acnetreatment 

https://lnkd.in/ejTC-DXS

Locus Biosciences operates as a precision medicine company focused on the development of CRISPR-engineered precision antimicrobials for the treatment of bacterial infections.

Locus Biosciences

Proteon Pharmaceuticals

Synlogic focuses on the development of synthetic biotic medicines for the treatment of metabolic and inflammatory diseases.

Synlogic

eGenesis is a biotechnology company engaged in the development of xenotransplantation therapies for patients with end-stage organ failure.

eGenesis

Scribe Therapeutics is a biotechnology company focused on the development of CRISPR-based genetic medicines for the treatment of genetic diseases.

Scribe Therapeutics

Tessera Therapeutics is a biotechnology company specializing in gene writing, a new biotechnology that enables the programming and reprogramming of the human genome.

Tessera Therapeutics

Korro Bio

Evofem is a biopharmaceutical company focused on the development and commercialization of innovative products to address unmet needs in women's sexual and reproductive health.

Evofem

Synthego is a biotechnology company that provides genome engineering solutions using CRISPR technology.

Synthego

Ginkgo Bioworks is a biotechnology company that designs custom microbes for customers across multiple markets, including food, agriculture, and pharmaceuticals.

Ginkgo Bioworks

Eligo Bioscience is a biotechnology company focused on the development of innovative microbiome therapies. The company leverages cutting-edge technology to engineer beneficial microbes that can specifically target and eliminate harmful bacteria, aiming to treat a range of diseases linked to the human microbiome.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 12, 2024 6:36 PM	eb128e38
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 12, 2024 11:24 PM	b426c609
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	32cdf004
crunchbase profile	general
li profile	general	May 12, 2024 6:36 PM	5fd17faa
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 12, 2024 6:36 PM	cbb9a204
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BIO:ELIGO

Eligo Bioscience